Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Omicron

COVID subvariant EG.5 and its spawn 'Eris' now dominant in the US

An omicron subvariant called EG.5 has become the most prevalent version of SARS-CoV-2 in the U.S. by a narrow margin, according to CDC estimates.

LiveScience

COVID-19 hospitalizations in the US are on the rise again, but not like before

COVID-19 hospital admissions are inching upward in the United States since early July

The Independent UK

New COVID mutant EG.5 driving up cases

Experts say the variant nicknamed Eris is thriving due to waning immunity and shifting baselines

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

Eris: What is the new Covid variant, and what are the symptoms?

Eris is the EG.5.1 strain of the Covid and a variant of Omicron

Evening Standard

UK Covid hotspots revealed as new variant Eris fuels surge in cases

The South-West of England has seen a surge in Covid cases and hospital admissions

The Independent UK

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

Covid Eris symptoms: All we know about new variant driving surge in cases

Eris desends from Omicron and is now the second most prevalent Covid variant in the UK

The Independent UK

Genuine Facts About Omicron, Delta, Naturally Acquired Immunity, And Vaccines

The facts surrounding the Delta variant provide a cautionary tale of misinformation about SARS-CoV-2

Zenger

Volunteers wanted for vaccine study

Chulalongkorn University's Faculty of Medicine is recruiting volunteers to take part in a new study aimed at assessing the efficacy of the Moderna bivalent Covid-19 vaccine in protecting against new sub-variants of the Omicron virus and whether or not it should be recommended as an alternative booster shot in Thailand.

Bangkok Post

These 5 Stories Reveal The Pivotal Points of the Covid-19 Pandemic — And What We Can Learn From Them

Five stories from The Conversation’s archives that helped illuminate complex issues at pivotal moments in the pandemic.

Inverse

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24.

The Hindu

Court Erred in Dismissing Challenge to L.A. City Employee COVID Vaccine Mandate

So the California Court of Appeal has held, concluding that there is enough of a factual dispute (under California's plaintiff-friendly pleading standards) for the case to go forward.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Do I need a booster vaccine if I recently had COVID? What if I'm not sure what I had?

In early 2021, recommendations about COVID vaccines were pretty straightforward – get two doses, as soon as you are eligible. A year later, we knew getting a third dose was important for protection against the new Omicron variant.

The Hindu

Regulator approves first Omicron-specific mRNA vaccine from India

India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM, developed by Pune-based Gennova Biopharmaceuticals Ltd, was approved under emergency use guidelines by the Drug Controller General of India late on June 19. This comes a year after the company got approval for GEMCOVAC-19, the country’s first m-RNA vaccine against…

The Independent UK

Next round of COVID-19 shots in fall will target latest omicron strain

The next round of COVID-19 vaccines will target one of the latest versions of the coronavirus

Tribune News Service

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

FDA advisers back updated COVID shots for fall vaccinations

A panel of advisers to the Food and Drug Administration has recommended revising the current COVID-19 vaccine so that it specifically targets omicron.

The Independent UK

FDA advisers consider changing COVID vaccine to target latest omicron strain

The COVID-19 vaccines are on track for a big recipe change this fall

The New Daily

We’re in another COVID wave. But it’s not like the others

Australia is in its fifth COVID wave, which has been brewing since February. It has grown slowly so many people may have not realised it.

The Conversation

We're in another COVID wave. But it’s not like the others

Each Omicron wave so far in Australia has had distinguishing features – the sharp rise and fall of BA.1, the widespread transmission among children and families in BA.2, a shift to more infections in older people with BA.5, then the confusing variant mix in the summer wave of 2022-23.

Salon

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

The Conversation

The first line of vaccines was highly effective at restricting COVID-19’s damage

After more than three years of COVID-19, the World Health Organization (WHO) reports that over 763 million infections, and nearly seven million deaths, have been attributed to SARS-CoV-2.

Caixin Global

China Rolls Out Its First Four-Valent Covid Vaccine as Infections Spike

The Sinocelltech-developed jab against the alpha, beta, delta and omicron variants is being offered in Beijing and several other cities

1 … 5 6 7 8

People

Rajendram Rajnarayanan

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

205 stories

the University of Melbourne

138 stories

NHMRC

121 stories

the National Health and Medical Research Council

California Court of Appeal

22 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.